Leadership Change at PharmaSGP Holding SE: Peter Gerckens Appointed CEO

PharmaSGP Holding SE has announced a significant leadership change. Peter Gerckens, currently serving as Chief Commercial Officer since July 2024, will assume the role of Chief Executive Officer on January 1, 2025. This decision was made by the Supervisory Board on November 5, 2024.

Peter Gerckens will succeed Natalie Weigand, who has chosen not to extend her contract which ends this year. Despite her departure from the CEO role, Natalie Weigand will continue to contribute to the company in an advisory capacity. The leadership transition is aimed at maintaining continuity and harnessing Peter Gerckens' expertise in commercial operations.

PharmaSGP Holding SE is situated in Gräfelfing, Germany and is listed on the Frankfurt Stock Exchange among others. The company is known for its focus on developing and marketing over-the-counter healthcare products.